IP Library › Granted Patent US 11,457,889
Granted Patent B2
US 11,457,889 · App. 17/210,013 · Granted Oct 4, 2022

System and method of non-invasive continuous echocardiographic monitoring

Inventor: Lazaro Eduardo Hernandez (Cooper City, FL)
A61B8/02A61B8/12A61B8/4236A61B8/4281A61B8/4494A61B8/461
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 11,457,889
App. No.
17/210,013
Granted
Oct 4, 2022
Kind
B2
Abstract

A system and a method of non-invasive continuous echocardiographic monitoring is provided with an ultrasound transducer and a bedside monitor. The beside monitor includes a monitor central processing unit (CPU). First, the ultrasound transducer is attached onto a specific skin portion of a patient. The specific skin portion is positioned adjacent to a patient's heart. Next, continuous echocardiographic data is sensed with the ultrasound transducer. After relaying the continuous echocardiographic data from the ultrasound transducer to the monitor CPU, the monitor CPU generates a real-time ultrasound image of the heart from the continuous echocardiographic data. Finally, the real-time ultrasound image is outputted with the bedside monitor. If the bedside monitor has a main screen, then the real-time ultrasound image is displayed through a picture-in-picture format with the main screen. Otherwise, if the beside monitor has an ancillary screen, then the real-time ultrasound image is exclusively displayed with the ancillary screen.

Claims (37)

1. A method of non-invasive continuous echocardiographic monitoring, the method comprising the steps of: (A) providing an adhesive pad, a pressure assistance device, an ultrasound transducer, and a bedside monitor, and wherein the bedside monitor includes a monitor central processing unit (CPU), and wherein the pressure assistance device includes a balloon and an air pump, wherein the balloon is integrated into the adhesive pad, and wherein the ultrasound transducer includes a flat body, a transducer head, a footprint, and a piezoelectric crystal arrangement, and wherein the flat body includes an outer body surface and an inner body surface, and wherein the transducer head is hingedly connected to the flat body with a projected angle set between 120 degrees to 180 degrees, and wherein the footprint and the piezoelectric crystal arrangement are integrated into the transducer head, and wherein the adhesive pad includes a first adhesive wing, a second adhesive wing, a third adhesive wing, and a fourth adhesive wing, and wherein the first adhesive wing, the second adhesive wing, the third adhesive wing, and the fourth adhesive wing are arranged into an H-shaped configuration; (B) attaching the ultrasound transducer onto a specific skin portion of a patient with the adhesive pad, positioning the balloon adjacent to the transducer head, opposite to the piezoelectric crystal arrangement, and pressing the transducer head against the specific skin portion by inflating the balloon with the air pump, wherein the specific skin portion is positioned adjacent to a heart of the patent, and wherein the first adhesive wing and the second adhesive wing are used to secure the transducer head against the specific skin portion, and wherein the third adhesive wing and the fourth adhesive wing are used to secure the flat body against the specific skin portion; (C) sensing continuous echocardiographic data with the ultrasound transducer; (D) relaying the continuous echocardiographic data from the ultrasound transducer to the monitor CPU; (E) generating a real-time ultrasound image of the heart from the continuous echocardiographic data with the monitor CPU, wherein the real-time ultrasound image is a two-dimensional four-chamber view of the heart; and (F) outputting the real-time ultrasound image with the bedside monitor.

2. The method of non-invasive continuous echocardiographic monitoring, the method as claimed in claim 1 comprising the steps of:

providing a quantity of ultrasound gel; and

applying the quantity of ultrasound gel in between the specific skin portion and the ultrasound transducer during step (B).

3. The method of non-invasive continuous echocardiographic monitoring, the method as claimed in claim 1 comprising the steps of:

wherein the method is configured to be used for a man or a child; and

orienting the footprint and the piezoelectric crystal arrangement towards the flat body by situating the transducer head at a projected reverse angle with the inner body surface during step (B), wherein the projected reverse angle is set between 120 degrees to 180 degrees.

4. The method of non-invasive continuous echocardiographic monitoring, the method as claimed in claim 1 comprising the steps of:

wherein the method is configured to be used for a woman; and

orienting the footprint and the piezoelectric crystal arrangement away from the flat body by situating the transducer head at a projected forward angle with the outer body surface during step (B), wherein the projected forward angle is set between 120 degrees to 180 degrees.

5. The method of non-invasive continuous echocardiographic monitoring, the method as claimed in claim 1 comprising the steps of:

providing a coaxial cable, wherein the ultrasound transducer and the monitor CPU are communicably coupled to each other by the coaxial cable; and

relaying the continuous echocardiographic data from the ultrasound transducer, through the coaxial cable, and to the monitor CPU during step (D).

6. The method of non-invasive continuous echocardiographic monitoring, the method as claimed in claim 1 comprising the steps of:

providing the bedside monitor with a main screen;

receiving other vital signs for the patient with the monitor CPU; and

displaying the real-time ultrasound image amongst the other vital signs through a picture-in-picture visual format with the main screen during step (F).

7. The method of non-invasive continuous echocardiographic monitoring, the method as claimed in claim 1 comprising the steps of:

providing the bedside monitor with an ancillary screen; and

displaying the real-time ultrasound image with the ancillary screen during step (F).

8. The method of non-invasive continuous echocardiographic monitoring, the method as claimed in claim 1 comprising the steps of:

extrapolating at least one medical diagnosis for the heart from the continuous echocardiographic data with the monitor CPU after step (D); and

further outputting the medical diagnosis with the bedside monitor during step (F).

9. The method of non-invasive continuous echocardiographic monitoring, the method as claimed in claim 8 , wherein the at least one medical diagnosis is selected from a group consisting of: cardiac function, pericardial effusion, intracardiac thrombus/vegetation, intracardiac volume, and combinations thereof.

10. The method of non-invasive continuous echocardiographic monitoring, the method as claimed in claim 1 comprising the steps of:

capturing a recording of the real-time ultrasound image with the monitor CPU during step (F);

prompting to replay the recording of the real-time ultrasound image with the bedside monitor after step (F); and

outputting the recording of the real-time ultrasound image with the bedside monitor, if the recording of the real-time ultrasound image is selected to be replayed by the bedside monitor.

11. The method of non-invasive continuous echocardiographic monitoring, the method as claimed in claim 1 comprising the steps of:

providing a normal ejection-fraction range managed by the monitor CPU;

deriving a real-time ejection-fraction measurement from the continuous echocardiographic data with the monitor CPU after step (D); and

outputting a life-threatening situation alert with the bedside monitor during step (F), if the real-time ejection-fraction measurement is outside of the normal ejection-fraction range.

12. The method of non-invasive continuous echocardiographic monitoring, the method as claimed in claim 11 , wherein the life-threatening situation alert is outputted with the bedside monitor, if the real-time ejection-fraction measurement is less than a lower end of the normal ejection-fraction range.

13. The method of non-invasive continuous echocardiographic monitoring, the method as claimed in claim 1 , wherein steps (B) through (F) are executed during a catheter interventional procedure.

14. The method of non-invasive continuous echocardiographic monitoring, the method as claimed in claim 1 , wherein steps (B) through (F) are executed during a cannula placement procedure for extracorporeal membrane oxygenation.

15. The method of non-invasive continuous echocardiographic monitoring, the method as claimed in claim 1 , wherein steps (B) through (F) are executed during a cannula removal procedure of extracorporeal membrane oxygenation.

16. The method of non-invasive continuous echocardiographic monitoring, the method as claimed in claim 1 , wherein steps (B) through (F) are executed during a pericardiocentesis procedure.

Assignments (4)
SUPPLEMENT NO. 1 TO INTELLECTUAL PROPERTY SECURITY AGREEMENT Recorded May 13, 2026
From: ECHONOUS, INC.
To: KENNEDY LEWIS INVESTMENT MANAGEMENT LLC, AS COLLATERAL AGENT
Reel/Frame 075572/0689 →
SECURITY INTEREST Recorded May 13, 2026
From: ECHONOUS, INC.
To: MS PRIVATE CREDIT ADMINISTRATIVE SERVICES LLC
Reel/Frame 074646/0670 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Aug 14, 2025
From: DL-HRT LLC
To: ECHONOUS, INC.
Reel/Frame 072020/0665 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jan 26, 2024
From: HERNANDEZ, LAZARO E
To: DL-HRT LLC
Reel/Frame 066253/0371 →
Continuity (2)
Provisional Application 63141465 · Jan 25, 2021
Related Publication 20220233163A1 · Jul 28, 2022